Markers to detect drinking during pregnancy

Alcohol Research and Health

Volumn 25, Issue 3, 2001, Pages 210-218

  Bearer, Cynthia F ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

AODR (alcohol or other drug related) biological markers; Birth defects; Carbohydrate deficient transferring; Cytochrome P450 2E1; Ethanol metabolism; Fetal alcohol effects; Gamma glutamyl transferase; Oxidation; Pregnancy

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER;

DRINKING BEHAVIOR; FEMALE; HUMAN; MEDICAL ETHICS; METABOLISM; PREGNANCY; REVIEW;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; ETHANOL; ETHICS, MEDICAL; FEMALE; HUMANS; PREGNANCY;

EID: 0035754571     PISSN: 0090838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ALLEN, J.P.; LITTEN, R.Z.; FERTIG, J.B.; AND SILLANAUKEE, P. Carbohydrate-deficient transferrin, gamma-glutamyltransferase, and macrocytic volume as biomarkers of alcohol problems in women. Alcoholism: Clinical and Experimental Research 24: 492-496, 2000.
2. BALDI, E.; BURRA, P.; PLEBANI, M.; AND SALVAGNINI, M. Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease. Italian Journal of Gastroenterology 25:429-432, 1993.
3. BEARER, C.F.; LEE, S.; SALVATOR, A.E.; ET AL. Ethyl linoleate in meconium: A biomarker for prenatal ethanol exposure. Alcoholism: Clinical and Experimental Research 23:487-493, 1999.
4. BEARER, C.F.; SALVATOR, A.E.; LEE, S.; ET AL. FAEE in meconium predicts outcome. Alcoholism: Clinical and Experimental Research 24:102A, 2000a.
5. BEARER, C.F.; SALVATOR, A.E.; WASHAH, S.K.; ET AL. Quantitating prenatal ethanol exposure by meconium analysis. Pediatric Research 47:81A, 2000b.
6. BEARER, C.F.; SALVATOR, A.E.; LEE, S.; BUCK, K.; AND SINGER, L.A comparison of FAEE in meconium to maternal self reported drinking in predicting neurodevelopment. Pediatric Research 49:183A, 2001.
7. BRINKMANN, B.; KOHLER, H.; BANASCHAK, S.; ET AL. ROC analysis of alcoholism markers - 100% specificity. International Journal of Legal Medicine 113:293,2000.
8. BUTCHER, G.P.; RHODES, J.M.; WALKER, R.; ET AL. The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification. Journal of Hepatology 19:105-109,1993.
9. DAY, N.L.; JASPERSE, D.; RICHARDSON, G.; ET AL. Prenatal exposure to alcohol: Effect on infant growth and morphologic characteristics. Pediatrics 84:536-541, 1989.
10. EBRAHIM, S.H.; LUMAN, E.T.; FLOYD, R.L; ET AL. Alcohol consumption by pregnant women in the United States during 1988-1995. Obstetrics and Gynecolgy 92:187-192, 1998.
11. GORSKI, N.P.; NOURALDIN, H.; DUBE, D.M.; ET AL. Reduced fatty acid ethyl ester synthase activity in the white blood cells of alcoholics. Alcoholism: Clinical and Experimental Research 20(2):268-274, 1996.
12. GROOPMAN, J.D. AND KENSLER, T.W. The light at the end of the tunnel for chemical-specific biomarkers: Daylight or headlight? Carcinogenesis 20:1-11, 1999.
13. HARASYMIW, J.W.; VINSON, D.C.; AND BEAN, P. The early detection of alcohol consumption (EDAC) score in the identification of heavy and at-risk drinkers from routine blood tests. Journal of Addictive Diseases 19:43-59, 2000.
14. HAZELETT, S.E.; LIEBELT, R.A.; BROWEN, W.J.; ET AL. Evaluation of acetaldehyde-modified hemoglobin and other markers of chronic heavy alcohol use: Effects of gender and hemoglobin concentration. Alcoholism: Clinical and Experimental Research 22 (8):1813-1819, 1998.
15. HELANDER, A.; VON WACHENFELDT, J.; HILTUNEN, A.; ET AL. Comparison of urinary 5-hydroxytryptophol, breath ethanol, and self-report for detection of recent alcohol use during outpatient treatment: A study on methadone patients. Drug and Alcohol Dependence 56(1):33-38, 1999.
16. JACOBSON, S.W.; JACOBSON, J.L.; AND SOKOL, R.F. Effects of alcohol exposure on infant reaction time. Alcoholism: Clinical and Experimental Research 18: 1125-1132, 1994.
17. KOECHLING, U.M., AND AMIT, Z. Relationship between blood catalase activity and drinking history in a human population, a possible biological marker of the affinity to consume alcohol. Alcohol and Alcoholism 27:181-188, 1992.
18. LITTLE, B.B.; SNELL, L.M.; ROSENFELD, C.R.; GILSTRAP, L.C.; AND GANT, N.F. Failure to recognize fetal alcohol syndrome in newborn infants. American Journal of Diseases in Childhood 144: 1142-1146, 1990.
19. LUCAS, D.; MENEZ, C.; GIRRE, C.; ET AL. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcoholism: Clinical and Experiment Research 19:362-366, 1995.
20. MUNDLE, G.; MUNKES, J.; ACERMANN, K.; AND MANN, K. Sex differences of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume in alcohol-dependent patients. Alcoholism: Clinical and Experimental Research 24: 1400-1405, 2000.
21. NIEMALA, O.; HALMESMAKI, E.; AND YLIKORKALA, O. Hemoglobin-acetaldehyde adducts are elevated in women carrying alcohol-damaged fetuses. Alcoholism: Clinical and Experimental Research 15:1007-1010, 1991.
22. RAUCY, J.L.; CURLEY, G.; AND CARPENTER, S.P. Use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic cytochrome P4502E1. Alcoholism: Clinical and Experimental Research 19:1369-1375, 1995.
23. RAUCY, J.L.; SCHULTZ, E.D.; WESTER, M.R.; ET AL. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metabolism and Disposition 25(12):1429-1435, 1997.
24. ROBINSON, M.K.; MYRICK, J.E.; HENDERSON, L.O.; ET AL. Two-dimensional protein electrophoresis and multiple hypothesis testing to detect potential serum protein biomarkers in children with fetal alcohol syndrome. Electrophoresis 16(7):1176-1183, 1995.
25. RUSSELL, M.; MARTIER, S.S.; SOKOL, R.J.; ET AL. Screening for pregnancy risk-drinking. Alcoholism: Clinical and Experimental Research 18:1156-1161, 1994.
26. SARKOLA, T.; ERIKSSON, C.J.; NIEMELA, O.; SILLANAUKEE, P.; AND HALMESMAKI, E. Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobinacetaldehyde adducts in the follow-up of pregnant women with alcohol abuse. Acta Obstetricia et Gynecologica Scandinavica 79(5)359-366, 2000.
27. SILLANAUKEE, P.; SEPPA, K.; KOIVULA, T.; ISRAEL, Y.; AND NIEMELA, O. Acetaldehyde-modified hemoglobin as a marker of alcohol consumption: Comparison of two new methods. Journal of Laboratory and Clinical Medicine 120(1):42-47, 1992.
28. SILLANAUKEE, P.; PONNIO, M.; AND SEPPA, K. Sialic acid: New potential marker of alcohol abuse. Alcoholism: Clinical and Experimental Research 6:1039-1043, 1999.
29. SOERBERG, B.L; SICINSKA, E.T.; BLODGET, E.; ET AL. Preanalytical variables affecting the quantification of fatty acid ethyl esters in plasma and serum samples. Clinical Chemistry 45:2183-2190, 1999.
30. STOLER, J.M.; HUNTINGTON, K.S.; PETERSON, C.M.; ET AL. The prenatal detection of significant alcohol exposure with maternal blood markers. Journal of Pediatrics 133(3):346-352, 1998.
31. STOWELL, L.; STOWELL, A.; GARRETT, N.; AND ROBINSON, G. Comparison of serum beta-hexosaminidase isoenzyme B activity with serum carbohydrate-deficient transferrin and other markers of alcohol abuse. Alcohol and Alcoholism 32:703, 1997.
32. STRATTON, K.; HOWE, C.; AND BATTAGLIA, F., eds. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. Washington, DC: National Academy Press, 1996.
33. STREISSGUTH, A.P.; BARR, H.M.; AND SAMPSON, P.D. Moderate prenatal alcohol exposure: Effects on child IQ and learning problems at age 7 1/2 years. Alcoholism: Clinical and Experimental Research 14:662-669, 1990.
34. Subcommittee on Reproductive and Neurodevelopmental Toxicology CoBM: Biologic Markers in Reproductive Toxicology. Washington, DC: National Academy Press, 1989.
35. WISNIEWSKI, K.E.; PULLARKAT, R.K.; HARIN, A.; AND VARTOLO, M. Increased urinary dolichol in newborns whose mothers were heavy alcohol users. Annals of Neurology 14:382, 1983.